Patents by Inventor Francois Lanza

Francois Lanza has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CD34+CD41DIM MEGAKARYOCYTES PROGENITORS AND USES THEREOF FOR PRODUCING PROPLATELET-BEARING MKS AND/OR PLATELETS
    Publication number: 20220135946
    Abstract: The invention relates to a method of producing CD34+CD41dim megakaryocyte (MK) progenitor cells, and a substantially pure cell population of megakaryocyte precursor cells obtained by said method and compositions thereof. The invention also relates to a method of producing proplatelet-bearing MKs and/or platelets using the CD34+CD41dim cells.
    Type: Application
    Filed: December 10, 2021
    Publication date: May 5, 2022
    Inventors: Catherine STRASSEL, Christian GACHET, François LANZA, Nathalie BROUARD
  • CD34CD41megakaryocytes progenitors and uses thereof for producing proplatelet-bearing MKs and/or platelets
    Patent number: 11236303
    Abstract: The invention relates to a method of producing CD34+CD4dim megakaryocyte (MK) progenitor cells, and substantially pure cell population of megakaryocyte precursor cells obtained by said method. The invention also relates to a method of producing proplatelet-bearing MKs and/or platelets using the CD34+CD4dim cells.
    Type: Grant
    Filed: July 22, 2016
    Date of Patent: February 1, 2022
    Assignees: INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM), ETABLISSMENT FRANçIS DU SANG, UNIVERSITÉ DE STRASBOURG
    Inventors: Catherine Strassel, Christian Gachet, François Lanza, Nathalie Brouard
  • CD34+CD41DIM MEGAKARYOCYTES PROGENITORS AND USES THEREOF FOR PRODUCING PROPLATELET-BEARING MKS AND/OR PLATELETS
    Publication number: 20180216068
    Abstract: The invention relates to a method of producing CD34+CD4dim megakaryocyte (MK) progenitor cells, and substantially pure cell population of megakaryocyte precursor cells obtained by said method. The invention also relates to a method of producing proplatelet-bearing MKs and/or platelets using the CD34+CD4dim cells.
    Type: Application
    Filed: July 22, 2016
    Publication date: August 2, 2018
    Inventors: Catherine STRASSEL, Christian GACHET, François LANZA, Nathalie BROUARD
  • Platelet glycoprotein v gene and uses
    Publication number: 20030135036
    Abstract: This invention relates to the glycoprotein v gene. Specifically, this invention discloses the sequence and structure of the glycoprotein v gene and the amino acid sequence of the glycoprotein v polypeptide. In addition, the evolutionary relationship of the glycoprotein v gene with other glycoproteins is described and several uses of the isolated glycoprotein v gene are shown.
    Type: Application
    Filed: August 6, 2002
    Publication date: July 17, 2003
    Applicant: COR Therapeutics Inc., a corporation of the State of California
    Inventors: Francois Lanza, David R. Phillips, Jean-Pierre Cazenave
  • Platelet glycoprotein V gene and uses
    Patent number: 6083688
    Abstract: This invention relates to the glycoprotein v gene. Specifically, this invention discloses the sequence and structure of the glycoprotein v gene and the amino acid sequence of the glycoprotein v polypeptide. In addition, the evolutionary relationship of the glycoprotein v gene with other glycoproteins is described and several uses of the isolated glycoprotein v gene are shown.
    Type: Grant
    Filed: February 10, 1994
    Date of Patent: July 4, 2000
    Assignee: Cor Therapeutics, Inc
    Inventors: Francois Lanza, David R. Phillips, Jean-Pierre Cazenave
  • Platelet glycoprotein V gene and uses
    Patent number: 6005089
    Abstract: This invention relates to the glycoprotein v gene. Specifically, this invention discloses the sequence and structure of the glycoprotein v gene and the amino acid sequence of the glycoprotein v polypeptide. In addition, the evolutionary relationship of the glycoprotein v gene with other glycoproteins is described and several uses of the isolated glycoprotein v gene are shown.
    Type: Grant
    Filed: January 26, 1996
    Date of Patent: December 21, 1999
    Assignee: Cor Therapeutics, Inc.
    Inventors: Francois Lanza, David R. Phillips, Jean-Pierre Cazenave